glp-1 low blood sugar Glucagon-like peptide-1 GLP-1 receptor agonists | How

1991 Breningstall GN: Carnitine deficiency syndromes

(Drugs 2024) Nine randomized controlled trials (RCTs) and one systematic review (SR) investigated the efficacy of L-carnitine in the supportive care of cancer: A full description of the RCTs can be found in Table 1

Second Nature

A recent retrospective review compared weight loss response and cardiometabolic changes in post-menopausal women using semaglutide in combination with and without hormone therapy

A recent study of moderately overweight women found that L-carnitine did not significantly alter body weight, body fat, or lean body mass

Taken together, the surveys point to a gap between the millions of people starting GLP-1s and the specialized support available to help them manage the side effects that can derail their progress